Trimipramine maleate vs. Risperidone: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Trimipramine maleate and Risperidone. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 187,086 people who take Trimipramine maleate and Risperidone, and is updated regularly.
What is Trimipramine maleate?
Trimipramine maleate has active ingredients of trimipramine maleate. It is often used in depression. eHealthMe is studying from 733 Trimipramine maleate users. Check the latest studies of Trimipramine maleate.
What is Risperidone?
Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 72,175 Risperidone users. Check the latest studies of Risperidone.
187,086 people who take Trimipramine maleate and Risperidone are studied.
Drugs being compared in this study:
- Risperidone (risperidone)
- Trimipramine Maleate (trimipramine maleate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Trimipramine Maleate:
- not at all: 0 %
- somewhat: 7.41 %
- moderate: 22.22 %
- high: 70.37 %
- very high: 0 %
Risperidone:
- not at all: 8.05 %
- somewhat: 23.97 %
- moderate: 33.23 %
- high: 26.44 %
- very high: 8.31 %
Want to compare Trimipramine maleate with Risperidone?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Trimipramine maleate (710 reports)
- Risperidone (70,804 reports)
Browse all side effects of Trimipramine maleate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Risperidone:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on trimipramine maleate and risperidone (the active ingredients of Trimipramine maleate and Risperidone, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Fosamax and Fentanyl - 2 seconds ago
- Drug interactions of Allopurinol and Lomotil - 4 seconds ago
- Drug interactions of Pralatrexate and Methotrexate - 6 seconds ago
- Could Genotropin cause Thyroid Diseases? - 10 seconds ago
- Drug interactions of Coumadin and Cetamide - 11 seconds ago
- Drug interactions of Fosamax and Ansaid - 11 seconds ago
- Drug interactions of Sertraline Hydrochloride and Meprobamate - 13 seconds ago
- Could Elmiron cause Injection Site Erythema? - 13 seconds ago
- Could Leflunomide cause Red Cell Distribution Width Decreased? - 27 seconds ago
- Could Optiray 300 cause Renal Impairment? - 29 seconds ago